News
PYPD
3.920
-1.51%
-0.060
PolyPid (PYPD) Receives a Buy from Roth MKM
TipRanks · 1d ago
Weekly Report: what happened at PYPD last week (1201-1205)?
Weekly Report · 5d ago
Roth Capital healthcare analyst holds an analyst/industry conference call
TipRanks · 12/05 19:40
Craig-Hallum Sticks to Their Buy Rating for PolyPid (PYPD)
TipRanks · 12/05 12:42
Roth MKM Keeps Their Buy Rating on PolyPid (PYPD)
TipRanks · 12/04 12:16
PolyPid Gains FDA Support for D-PLEX100 NDA Submission
TipRanks · 12/03 13:57
POLYPID LTD - FDA AGREED TO A ROLLING NDA REVIEW, ALLOWING POLYPID TO SUBMIT FIRST COMPLETED SECTIONS IN EARLY 2026
Reuters · 12/03 13:30
Weekly Report: what happened at PYPD last week (1124-1128)?
Weekly Report · 12/01 09:57
PolyPid Expands Share Offering to Strengthen Financial Position
TipRanks · 11/26 21:29
Weekly Report: what happened at PYPD last week (1117-1121)?
Weekly Report · 11/24 10:01
Weekly Report: what happened at PYPD last week (1110-1114)?
Weekly Report · 11/17 10:00
PolyPid Is Maintained at Buy by Roth Capital
Dow Jones · 11/13 16:48
PolyPid Price Target Cut to $9.00/Share From $10.00 by Roth Capital
Dow Jones · 11/13 16:48
Roth Capital Maintains Buy on PolyPid, Lowers Price Target to $9
Benzinga · 11/13 16:38
Roth MKM Remains a Buy on PolyPid (PYPD)
TipRanks · 11/13 11:37
PolyPid price target lowered to $9 from $10 at Roth Capital
TipRanks · 11/13 11:16
PolyPid Ltd. Advances Towards Key Milestones in 2025
TipRanks · 11/13 04:02
PolyPid Ltd. Earnings Call: Progress and Potential
TipRanks · 11/13 00:07
PolyPid’s Promising Future: Buy Rating Backed by D-PLEX100 Progress and Expanding Drug Delivery Pipeline
TipRanks · 11/12 16:55
More
Webull provides a variety of real-time PYPD stock news. You can receive the latest news about Polypid Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.